[Asia Economy Reporter Changhwan Lee] The Korea Disease Control and Prevention Agency has allowed the number of vaccinations per vial of COVID-19 vaccine used domestically to be increased by 1 to 2 people at vaccination sites.


The COVID-19 Vaccination Response Promotion Team distributed the 'Vaccination Implementation Method' containing this information to vaccination sites nationwide on the 27th.


The Promotion Team announced guidelines stating that when using the special 'Low Dead Space syringe' (LDS) developed by domestic companies, the number of doses per vial of the Pfizer vaccine can be increased from 6 to 7, and for the AstraZeneca vaccine, the number of doses can be increased from 10 to 11?12.


This increase in the number of doses per vial is the world's first case.


In the official document, the Promotion Team explained, "When using the low dead space sterile syringe, if there is any residual amount remaining after the recommended number of doses per vial, additional vaccinations can be administered with the residual amount to reduce waste."



The low dead space syringe is a special syringe designed to minimize wasted vaccine by having almost no space between the piston and the needle.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing